Search for: "Regeneron"
Results 81 - 100
of 224
Sort by Relevance
|
Sort by Date
28 Oct 2020, 8:38 am
Then, on Oct. 7, two days after the president returned to the White House after being hospitalized with COVID-19, the respiratory disease caused by the novel coronavirus, he tweeted a video message in which he acknowledged receiving Regeneron’s experimental antibody cocktail. [read post]
23 Oct 2020, 2:02 pm
I assume you're referencing Regeneron. [read post]
18 Oct 2020, 9:02 am
This year, the expert panel will debate whether the Supreme Court reached the correct conclusion in the Regeneron Pharmaceuticals Inc v Kymab Ltd [2020] UKSC 27 case. [read post]
15 Oct 2020, 9:40 pm
” In the first IPR, Sanofi-Aventis, Genzyme Corp., and Regeneron Pharmaceuticals (collectively “Sanofi”) challenged the ‘487 patent, and the PTAB found all of the challenged claims to be invalid. [read post]
11 Oct 2020, 11:23 am
” So, now Americans may be racing to reference works to learn more about coronavirus care with monoclonal antibodies, specifically those developed by the Big Pharma firm Regeneron. [read post]
9 Oct 2020, 10:15 am
Google; CRISPR gene editing inventors Jennifer Doudna and Emmanuelle Charpentier awarded Nobel Prize; IBM announces that it will separate its managed infrastructure services unit to focus on its hybrid cloud business; and Regeneron seeks emergency approval for its COVID-19 therapy but also faces patent infringement charges over its use of a reagent used in vaccine testing assays. [read post]
8 Oct 2020, 10:53 am
A short 24 hours [after receiving the drug Regeneron], I was feeling great, I wanted to get out of the hospital and that’s what I want for everybody. [read post]
7 Oct 2020, 4:15 am
(Regeneron); Pfizer, Inc. [read post]
7 Oct 2020, 4:15 am
(Regeneron); Pfizer, Inc. [read post]
22 Sep 2020, 2:15 pm
Recent Bevou Label Change in Europe Adds Information About Retinal Vasculitis and Retinal Vascular Occlusion (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-September 2020 Novartis announced the results of a Phase 3 head-to-head study comparing its relatively new eye medicine Beovu to Eylea, a more well-established competing eye drug product from Regeneron. [read post]
13 Aug 2020, 12:56 am
The UK follows the EPO approach, see for example Regeneron v Genentech ([2012] EWHC 657 (Pat)). [read post]
19 Jul 2020, 9:38 am
| BREAKING: Kymab caught the mouse as sufficiency strengthened by UK Supreme Court in Regeneron battle ([2020] UKSC 27) | When the consumer getting the mark all wrong might be good for the brand holder | [Guest post] Shaping the right form of (IP) protection: The Moon Boot decision(s) | [Guest post] Swedish Patent and Market Court of Appeal applies C-21/18 Textilis in long-running pillow fight | ECtHR finds Russian website blocking approach contrary to Article 10 ECHR (freedom of expression… [read post]
9 Jul 2020, 1:31 am
Supreme Court against New York biotechnology giant Regeneron in June. [read post]
7 Jul 2020, 11:08 am
by Dennis Crouch Regeneron Pharmaceuticals Inc. v Kymab Ltd. [read post]
3 Jul 2020, 10:55 pm
Author George Shuklib Licence CC NY-SA 1.0 Source Wikipedia Mouse Jane Lambert Supreme Court (Lords Reed, Hodge, Briggs and Sales and Lady Black) Regeneron Pharmaceuticals Inc v Kymab Ltd [2020] UKSC 27 (24 June 2020) This was an appeal from the Court of Appeal's judgment in Regeneron Pharmaceuticals, Inc v Kymab Ltd and another [2018] EWCA Civ 671 (28 March 2018). [read post]
2 Jul 2020, 6:13 am
However, Kymab claimed that Regeneron’s product claims were not enabled and thus not valid. [read post]
1 Jul 2020, 1:15 am
.'s decision to deny an interim injunction against a generic company which launched at risk.Fellow GuestKat Rose Hughes reported on the judgment of the UK Supreme Court in Regeneron v Kymab, which found Regeneron's patents to be invalid for insufficiency, overturning the Court of Appeal decision and confirming the UK's strong sufficiency requirement.Trade MarksPermaKat Neil J. [read post]
25 Jun 2020, 4:37 pm
Regeneron allegedly disguised the kickbacks as charitable contributions to a foundation. [read post]
25 Jun 2020, 9:59 am
(Regeneron), of Tarrytown, N.Y. [read post]
24 Jun 2020, 1:15 pm
(Regeneron Pharmaceuticals Inc v Kymab Ltd. [2020] UKSC 27.) [read post]
